Rhode Island Public Radio recently hosted a series of informative radio segments on hepatitis C. Over the next couple of weeks, we’ll be posting this series on StepUpToHep. The series covers a range of topics relevant to both patients and providers, including infection statistics, populations at highest risk, the newest pharmaceuticals designed to combat hepatitis C, and barriers for patients attempting to access treatment.
Click here to listen to Part One of At the Crossroads: A Tale of Two Epidemics.
Synopsis: One infectious disease – Ebola – is dominating the headlines now. But there’s another that affects far more people around the world, including here in the U.S. Hepatitis C infects an estimated five million Americans, though most of them don’t know it, because it takes years for symptoms to emerge. Now, deaths from hepatitis C are on the rise in baby boomers. And throughout New England, new infections are creeping up among a younger generation. Less than a year ago, their only options for treatment were complicated regimens of injections that didn’t always work. But brand new drugs could change everything. That is, if the cost doesn’t break the bank.
If you are a person living with hepatitis C and have questions after reading this article or listening to the public radio broadcast, please call our helpline at 1-800-522-HEPC (4372).